Mitochondrial-Derived Peptides: What They Are and Why Researchers Study Them

Mitochondria are traditionally described as the “powerhouses” of the cell because of their central role in producing ATP. Modern mitochondrial biology has revealed something more interesting: mitochondria also communicate.

They respond to changes in energy availability, oxidative stress, exercise, nutrient status, and cellular damage — and they can send signals back to the nucleus and throughout the cell. One emerging component of this communication system is a group of small peptides known as mitochondrial-derived peptides (MDPs).

Unlike conventional peptides encoded by nuclear DNA, MDPs are encoded by short open reading frames within the mitochondrial genome. Current research has identified several members of this group, including Humanin, small Humanin-like peptides (SHLPs), and MOTS-c.

This relatively new area of molecular biology has opened another avenue for researchers studying mitochondrial function, metabolism, cellular stress, aging, and exercise physiology. For the MOTS-c-specific pathway work, see the Ultimate MOTS-C Research Guide and MOTS-c in mitochondrial research.

What Are Mitochondrial-Derived Peptides?

Mitochondrial-derived peptides are small bioactive peptides encoded by short open reading frames (sORFs) within mitochondrial DNA. This is significant because mitochondria have their own genome.

For many years, mitochondrial DNA was primarily studied in the context of encoding components required for mitochondrial function. The discovery of peptide-coding sequences within mitochondrial DNA expanded the potential biological role of the mitochondrial genome.

Researchers currently recognize three major groups of mitochondrial-derived peptides:

Humanin was the first mitochondrial-derived peptide described, while MOTS-c was subsequently identified as another peptide encoded within mitochondrial DNA. The discovery of these molecules has led researchers to investigate whether mitochondria function not only as metabolic organelles, but also as signaling platforms capable of producing regulatory peptides.

Why Is This Discovery Important?

The traditional view of mitochondrial biology focuses heavily on ATP production, oxidative phosphorylation, the citric acid cycle, fatty-acid oxidation, reactive oxygen species, calcium handling, and regulation of apoptosis. These functions remain fundamental.

However, mitochondria are also highly responsive to changes in the cellular environment. When energy availability changes, mitochondrial activity changes. When oxidative stress increases, mitochondria respond. During exercise, mitochondrial demand increases. During aging, mitochondrial function can change.

The discovery of MDPs provides researchers with another possible mechanism through which mitochondria can communicate information about these conditions to the rest of the cell. This concept is closely related to mitochondrial retrograde signaling.

What Is Mitochondrial Retrograde Signaling?

The term retrograde signaling describes communication originating from mitochondria and traveling back toward other cellular systems, particularly the nucleus.

Mitochondrial-derived peptides are increasingly being studied as components of this signaling network. Research reviews describe MDPs as potential mediators of communication between mitochondrial status, cellular metabolism, stress responses, and gene expression.

Humanin: The First Mitochondrial-Derived Peptide

Humanin was the first widely characterized mitochondrial-derived peptide. It is encoded within the MT-RNR2 region, which produces the mitochondrial 16S ribosomal RNA.

Humanin is a relatively small peptide and has been investigated extensively in cellular stress, apoptosis, metabolism, cardiovascular biology, and neuroscience research. Experimental literature has examined Humanin in models involving oxidative stress, apoptosis, metabolic dysfunction, cardiovascular biology, neurodegeneration, aging, and cellular stress.

A major review describes Humanin as a mitochondrial-derived cytoprotective peptide and summarizes experimental evidence involving several stress-response mechanisms. These findings do not mean that Humanin is an established treatment for those conditions. They demonstrate why researchers continue to investigate its underlying biology.

Small Humanin-Like Peptides

The Humanin region of mitochondrial DNA contains additional short open reading frames that can encode small Humanin-like peptides, commonly abbreviated as SHLPs. Researchers have described SHLP1 through SHLP6 as members of the mitochondrial-derived peptide family.

These peptides have generated interest because they demonstrate that the mitochondrial genome may contain more peptide-coding information than previously appreciated. In other words, one mitochondrial RNA region can give rise to multiple potential signaling peptides.

Instead of thinking of mitochondrial DNA as simply producing a limited collection of mitochondrial components, researchers are beginning to examine it as a source of regulatory micropeptides.

MOTS-C: Another Major Mitochondrial-Derived Peptide

The third major category of MDP research centers around MOTS-c. MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA-c. It is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA region.

MOTS-c has received substantial attention because of its connection to metabolic signaling. Researchers have investigated it in relation to AMPK, glucose metabolism, metabolic stress, skeletal muscle, exercise, mitochondrial function, cellular stress, aging, and metabolic adaptation.

A major review describes MOTS-c as a mitochondrial-derived peptide involved in stress and metabolic signaling, with particular interest surrounding the folate–AICAR–AMPK pathway. For the full MOTS-c cluster, see the Ultimate MOTS-C Research Guide, MOTS-c for mitochondrial research, and MOTS-c vs. NAD+.

MDPs and AMPK Signaling

AMPK, or AMP-activated protein kinase, is one of the most important energy-sensing pathways investigated in metabolic research. AMPK responds to changes in cellular energy status and helps coordinate processes involved in energy production and utilization.

MOTS-c research has particularly focused on a proposed MOTS-c → folate cycle → AICAR → AMPK relationship. This makes MOTS-c especially interesting to researchers studying metabolic adaptation.

Mitochondrial-Derived Peptides and Exercise

Exercise places significant metabolic demands on skeletal muscle. During physical activity, cells experience changes in ATP demand, oxygen consumption, mitochondrial respiration, calcium signaling, reactive oxygen species, energy availability, and AMPK activity.

Because MDPs appear to respond to metabolic and cellular stress, researchers have investigated their relationship with exercise. MOTS-c has been particularly studied in this context. Reviews have discussed MDP responses to exercise and their potential involvement in metabolic adaptation.

A 2026 study reported that MOTS-c administration improved skeletal-muscle mitochondrial bioenergetic performance in two transgenic mouse models and identified dependence on both PGC-1α and AMPK. That work moves the research beyond circulating peptide concentrations and toward direct examination of mitochondrial function.

However, the same researchers included a human exercise experiment and did not observe a change in the arterio-venous difference of MOTS-c during the specific exercise protocol studied. Different experimental systems can produce different findings. Animal administration studies, cell-culture experiments, observational human studies, and controlled human physiology experiments answer different questions.

MDPs and Cellular Stress

Another major research area is cellular stress adaptation. Mitochondrial stress can influence reactive oxygen species, energy metabolism, protein homeostasis, apoptotic signaling, antioxidant responses, and gene expression.

Mitochondrial-derived peptides are being investigated as potential components of these responses. MOTS-c research, for example, has described stress-dependent movement toward the nucleus and interactions with transcriptional programs involving antioxidant response elements. Humanin research has similarly examined mechanisms involving apoptosis and cellular survival pathways.

This suggests that different MDPs may participate in different portions of the cellular response to stress.

MDPs and Gene Regulation

One of the most interesting questions in mitochondrial peptide research is how a short peptide can influence cellular gene expression. The proposed mechanism differs depending on the peptide.

For MOTS-c, researchers have reported stress-dependent nuclear translocation and effects on transcriptional regulation. For Humanin, research has investigated interactions with proteins involved in apoptosis and cellular survival.

This provides a potential molecular connection between mitochondrial metabolism and nuclear gene regulation.

MDPs and Metabolic Research

Metabolism is one of the most heavily investigated areas of MDP research. Researchers have studied these peptides in relation to glucose metabolism, insulin signaling, energy expenditure, metabolic stress, obesity models, diabetes models, aging, skeletal muscle, and mitochondrial function.

A 2024 review identified Humanin, MOTS-c, and SHLP1–6 as the currently recognized major MDP groups and discussed their relationships with metabolic physiology. A systematic review and meta-analysis has also examined associations between circulating MOTS-c concentrations and metabolic states, highlighting that results can vary among populations and study designs.

MDPs and Aging Research

Aging is another major area of interest. Mitochondrial function changes over the lifespan, and researchers investigate relationships between aging and oxidative stress, mitochondrial dysfunction, metabolic flexibility, muscle homeostasis, cellular senescence, energy metabolism, and stress responses.

Several reviews have discussed relationships between mitochondrial-derived peptides and aging biology. MOTS-c research has received particular attention because some experimental studies have reported age-associated changes in MOTS-c levels and investigated its role in metabolic and physical-function models.

These findings are an area of active investigation rather than evidence that MDPs constitute established anti-aging therapies. For U.S. compounding context, see the FDA peptide compounding update.

Humanin vs. SHLPs vs. MOTS-C

These compounds belong to the same broad biological family but should not be treated as interchangeable research molecules. Their molecular sequences and biological activities differ.

Why Researchers Are Interested in MDPs

1. The mitochondrial genome may encode more functional information than previously appreciated. Short open reading frames can produce biologically active peptides.
2. Mitochondria actively communicate with the nucleus. Retrograde signaling provides a mechanism for translating mitochondrial conditions into broader cellular responses.
3. MDPs connect mitochondrial biology with metabolism. MOTS-c and Humanin research has linked mitochondrial-derived peptides with metabolic signaling and cellular stress responses.
4. Exercise may influence mitochondrial signaling. Exercise-associated changes in MDP biology are an active area of investigation.
5. MDPs may provide new experimental models. Researchers can investigate mitochondrial signaling using defined peptide sequences and controlled experimental systems.

Why Analytical Characterization Matters

As with any synthetic peptide research, the quality and identity of the experimental material matter. If a researcher is studying a specific peptide sequence, they need confidence that the material being tested corresponds to the intended compound.

• HPLC can be used to assess chromatographic purity and separate the target peptide from other detectable components.
• LC-MS combines chromatographic separation with mass analysis and can provide information useful for molecular identity and characterization.
• A Certificate of Analysis can consolidate analytical information for a particular batch, depending on the testing performed.

See What Does 99% HPLC Purity Mean?, Peptide Purity, HPLC, LC-MS & COAs, and the Peptide Storage & Handling Guide.

What Researchers Should Keep in Mind

MDP research is interesting, but the field is still developing. A useful evidence hierarchy is:

Each step provides different information. A mechanism demonstrated in cultured cells does not establish that the same mechanism produces a clinically meaningful effect in humans. Likewise, an effect observed after administration of synthetic MOTS-c to mice does not automatically establish that administering MOTS-c to humans produces the same result.

This is particularly important with emerging peptides because online discussions can easily blur the distinction between biological mechanism and proven therapeutic effect. For researchers, maintaining that distinction is essential.

Where the Field Is Going

Mitochondrial-derived peptide research is expanding into MDP structure and stability, receptor and intracellular targets, mitochondrial retrograde signaling, metabolic regulation, exercise physiology, skeletal-muscle biology, aging, cellular stress, neurobiology, cardiovascular biology, human biomarkers, and mitochondrial bioenergetics.

The 2026 MOTS-c mitochondrial-bioenergetics study is an example of how the field is moving toward more detailed mechanistic experiments rather than relying solely on broad metabolic endpoints. Future research will be particularly important for determining which observations from experimental models translate into reproducible human physiology.

Frequently Asked Questions

Related Reading on Summit Pep Labs

• Ultimate MOTS-C Research Guide
• MOTS-C Benefits for Mitochondrial Research
• MOTS-C vs. NAD+
• MOTS-C Research Product
• FDA Peptide Compounding Update
• What Does 99% HPLC Purity Mean?
• Peptide Purity, HPLC, LC-MS & COAs
• Peptide Half-Life Explained
• Lyophilized Peptides Explained

External Research References

• Merry et al., 2020 — Mitochondrial-derived peptides in energy metabolism
• Wan et al., 2023 — MOTS-c, stress, metabolism, and aging
• Mohtashami et al., 2022 — MOTS-c in human aging and age-related diseases
• Kal et al., 2024 — MDPs: antidiabetic functions and evolutionary perspectives
• Hazafa et al., 2021 — Humanin as a mitochondrial-derived peptide in apoptosis-related research
• Gudiksen et al., 2026 — MOTS-c, mitochondrial bioenergetics, PGC-1α, and AMPK
• Systematic review and meta-analysis — circulating MDPs and metabolic states
• Lee et al., 2015 — Original MOTS-c characterization in Cell Metabolism

Final Thoughts

Mitochondrial-derived peptides represent one of the more interesting developments in modern mitochondrial biology. The discovery of Humanin, SHLPs, and MOTS-c demonstrated that the mitochondrial genome contains short open reading frames capable of producing peptides with biological activity.

This has expanded the traditional concept of mitochondria from energy-producing organelles into dynamic signaling centers capable of communicating information about cellular conditions.

Among these peptides, MOTS-c has become particularly interesting because of its relationship with AMPK, metabolic signaling, exercise physiology, and mitochondrial adaptation. Humanin has generated extensive research surrounding cellular stress, apoptosis, and cytoprotective signaling, while SHLPs represent an expanding area of mitochondrial peptide research.

The field is still developing. The most scientifically appropriate way to view mitochondrial-derived peptides is as an emerging class of biological signaling molecules and research tools, rather than as established therapeutic solutions.

For researchers, the real significance may ultimately be the insight these peptides provide into a fundamental biological question: how do mitochondria communicate their condition to the rest of the cell? That question remains an active area of investigation — and MDPs may be an important part of the answer.